corporations

Portuguese fund Iberis Capital invests 2 million in Eurox Group

Published

4 years ago

9 April, 2022

Reading Time: 2 minutes

The EUROX Group announced that it had obtained 4,4 million euros in capitalization by private investors. The company, which is headquartered in Germany and has operations in the of medical cannabis in several European countries, including Portugal, highlighted the investment of two million euros by the Portuguese fund Iberis Capital.

The Eurox Group (“EUROX”) raised a total of 4,4 million euros from new and existing investors, with a premium liquors of approximately 62% of its fundraising in July 2021. According to an announcement by Seed Inovations Ltd., a listed company in alternative investment markets with a fast-growing portfolio of businesses and a focus on medical cannabis, health and well-being, existing investors (including Seed) invested an additional €2,4 million by subscribing to a new class of preference shares on EUROX (with liquidation reference).

Portuguese investments

The operation was marked by the entry of Iberis Capital, a private equity management fund operating in Portugal, with more than 230 million euros of assets under its management. This new fund, which made its initial investment in the EUROX Group through the Iberis Bluetech Fund, has subscribed €2 million through Secured Convertible Loan Securities ('CLN') and marks its first investment in the medical cannabis sector. This CLN is not remunerated, is guaranteed against the assets of EUROX and will be converted into Preference Shares immediately at the option of Iberis; on the fifth anniversary of this CLN; or through a new fundraising of €10 million or more.

The Eurox Group owns the entirety of a Portuguese subsidiary which, according to the statement, already has a provisional license (often called a “pre-licence”) granted by Infarmed, the Portuguese National Authority for Medicines and Health Products. Eurox Portugal is currently building its cultivation facilities to ensure vertical integration and long-term supply independence. Bernhard Babel, co-manager EUROX, commented that he was “very pleased to announce our most recent successful fundraising and, in particular, our new relationship with Iberis Capital. Being well funded will allow us to step up our investment in pharmaceutical development.”

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

Antonio João Costa

I am one of the directors of CannaReporter, which I founded together with Laura Ramos. I am from the unique Island of Madeira, where I currently reside. While I was in Lisbon at FCUL studying Physical Engineering, I became involved in the national hemp and cannabis scene and participated in several associations, some of which I am still a member of. I follow the global industry and especially legislative advances regarding the different uses of cannabis.

I can be contacted by email at joao.costa@cannareporter.eu